Pricing Log in Create free account

Haleon PLC Sponsored ADR (HLN) vs Teva Pharmaceutical Industries Ltd. (TEVA)

Haleon PLC Sponsored ADR and Teva Pharmaceutical Industries Ltd. are both Drug Manufacturers Specialty & Generic companies. Teva Pharmaceutical Industries Ltd. is the larger, with a market value of $48.7B against $40.2B — 1.2× the size. Haleon PLC Sponsored ADR trades at the lower P/E: 20.5× against 92.6×. Haleon PLC Sponsored ADR has the higher net margin (11.2% vs 2.94%) and the lower return on invested capital (0.00% vs 4.09%). Across the 21 metrics below, Haleon PLC Sponsored ADR leads on 15 and Teva Pharmaceutical Industries Ltd. on 6.

Valuation

Metric HLN TEVA Drug Manufacturers Specialty & Generic median
P/E 20.48 92.59 20.55
P/S 2.32 2.82 2.08
P/B 1.90 6.09 1.79
Price to free cash flow 9.23 36.64 16.29
EV/EBITDA 12.22 26.25 12.22
EV/Sales 2.87 3.56 2.87
Earnings yield 4.88% 1.08% (15.94%)
Free cash flow yield 10.84% 2.73% 0.00%

Profitability

Metric HLN TEVA Drug Manufacturers Specialty & Generic median
Gross margin 62.22% 53.51% 53.51%
Operating margin 17.93% 7.84% 0.00%
Net margin 11.18% 2.94% (2.45%)
Free cash flow margin 0.00% 7.71% 0.00%
Return on equity 0.00% 6.65% (0.80%)
Return on assets 0.00% 1.27% (1.67%)
Return on invested capital 0.00% 4.09% 0.00%

Growth

Metric HLN TEVA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 2.71% 5.22%
EPS growth (last fiscal year) 22.50% 183.45% 42.91%
Revenue growth, 5-year CAGR 1.43% 0.71% 7.24%
Net income growth, 5-year CAGR 6.98% 0.00% 0.00%

Health

Metric HLN TEVA Drug Manufacturers Specialty & Generic median
Debt to equity 0.50 2.09 0.04
Current ratio 0.69 0.95 2.41
Net debt to EBITDA 2.63 4.19 1.01

Dividend

Metric HLN TEVA Drug Manufacturers Specialty & Generic median
Dividend yield 2.16% — 1.45%
Payout ratio — — 0.27

Size

Metric HLN TEVA Drug Manufacturers Specialty & Generic median
Market cap 40.24b 48.69b 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack